PD-L1 Expression in Endometrial Serous Carcinoma and Its Prognostic Significance-Reference-Cited by-同舟云学术

PD-L1 Expression in Endometrial Serous Carcinoma and Its Prognostic Significance

Published:2021-12 Issue: Volume:Volume 13 Page:9157-9165
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Zhang Tao^ORCID,Liu Qin,Zhu Yingfan,Zhang Songfa,Peng Qiaohua,Strickland Amanda Louise,Zheng Wenxin^ORCID,Zhou Feng

Publisher

Informa UK Limited

Subject

Oncology

Reference42 articles.

1. Cancer statistics, 2020

2. Endometrial Cancer

3. Uterine papillary serous cancer: A review of the literature

4. World Health Organization. Classification of Tumours: Female Genital Tumours. 5th ed. Lyon (France): International Agency for Research on Cancer; 2020.

5. Pathogenesis and Clinical Management of Uterine Serous Carcinoma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation of BUB1 and BUB1B with the development and prognosis of endometrial cancer;Scientific Reports;2024-07-24

2. Prevalence and prognostic role of PD-L1 in patients with gynecological cancers: A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2023-09

3. Targeting DNA Damage Repair and Immune Checkpoint Proteins for Optimizing the Treatment of Endometrial Cancer;Pharmaceutics;2023-08-30

4. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Genomic and Immunohistochemical Profiling with Comprehensive Clinicopathological Analysis of 17 Consecutive Cases from a Single Institution;Biomedicines;2023-08-15

5. Tumor-TME Bipartite Landscape of PD-1/PD-L1 in Endometrial Cancers;International Journal of Molecular Sciences;2023-07-04